GlassScriptPhysician profile
Angelo R Derosalia
NPI 1649444183
$4,937.45
in general payments reported to CMS, 2019-2025
40 companies · $767 in 2025
The $767 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $308 · 2021: $561 · 2022: $546 · 2023: $1,184 · 2024: $945 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,861 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,860.73 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $711.75 | 2019-2024 | Myrbetriq, Veozah |
| Myriad Genetic Laboratories, INC. | $625.11 | 2020-2025 | Prolaris, Myrisk |
| 180 Medical, INC. | $343.61 | 2019-2025 | Gentlecath Glide, Gentlecath |
| Dendreon Pharmaceuticals LLC | $277.41 | 2019-2025 | Provenge |
| Olympus America INC. | $273.77 | 2022-2025 | Itind System |
| Teleflex LLC | $261.26 | 2023 | Urolift |
| Abbvie INC. | $205.77 | 2019-2025 | Botox |
| Neotract INC. | $183.65 | 2019-2020 | |
| Accord Healthcare, INC. | $154.50 | 2022-2024 | |
| Pfizer INC. | $152.62 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $144.98 | 2019-2025 | Adstiladrin |
| Histosonics, INC. | $142.42 | 2025 | |
| Urogen Pharma, INC. | $137.27 | 2022-2024 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $133.59 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $131.39 | 2019-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $111.01 | 2022-2023 | |
| Tolmar, INC. | $103.16 | 2023-2024 | |
| Coloplast Corp | $98.52 | 2023-2024 | Coloplast Tfl Drive, Speedicath |
| Astrazeneca Pharmaceuticals LP | $74.48 | 2022-2025 | Imfinzi |
| Alnylam Pharmaceuticals INC. | $71.49 | 2023 | Givlaari |
| Antares Pharma, INC. | $68.19 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Boston Scientific Corporation | $63.98 | 2020-2024 | Ams 700 |
| Allergan, INC. | $56.95 | 2019-2022 | |
| Procept Biorobotics Corporation | $46.86 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| C. R. Bard, INC. & Subsidiaries | $46.41 | 2024 | Bard Urinary Drainage Bag |
| Telix Pharmaceuticals | $41.54 | 2023-2025 | Illuccix |
| Urovant Sciences INC | $35.77 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $31.98 | 2023-2025 | Orgovyx, Gemtesa |
| Laborie Medical Technologies Corp. | $29.38 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $23.45 | 2024 | Keytruda |
| Myovant Sciences INC. | $20.59 | 2021 | |
| Medtronic, INC. | $19.84 | 2025 | Altaviva |
| Otsuka America Pharmaceutical, INC. | $17.17 | 2024 | Jynarque |
| Agiliti Surgical, INC. | $16.82 | 2025 | Siemens Healthineers Varian Cryocare, Koelis Trinity Mri/US Fusion |
| Verity Pharmaceuticals INC. | $16.24 | 2021 | |
| Endo Pharmaceuticals INC. | $14.83 | 2020 | |
| Clarus Therapeutics INC. | $14.21 | 2021 | |
| Cook Medical LLC | $12.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Medtronic USA, INC. | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Derosalia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.